1
Erschienen: Ottawa, Ont.,
Canadian Agency for Drugs and Technologies in Health,
May 2020
Version 1.0.
von
Banerjee, S.
|
Butcher, R.
2
Erschienen: Ottawa (ON),
Canadian Agency for Drugs and Technologies in Health,
March 27, 2020
Version: 1.0.
von
Li, Y.
|
Argáez, C.
3
Erschienen: Ottawa,
Canadian Agency for Drugs and Technologies in Health,
February 25, 2020
Version: 1.0.
von
Peprah, K.
|
MacDougall, D.
4
Erschienen: Rockville, MD,
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services,
October 2019
Technical brief
- number 33
von
Brasure, M.
5
Erschienen: Ottawa (ON),
Canadian Agency for Drugs and Technologies in Health,
May 07, 2019
Version 1.0.
von
Banerjee, S.
|
Argáez, C.
6
Erschienen: Ottawa (ON),
Canadian Agency for Drugs and Technologies in Health,
June 25, 2019
Version: 1.0.
von
Lachance, C.
|
McCormack, S.
7
Erschienen: Ottawa (ON),
Canadian Agency for Drugs and Technologies in Health,
May 10, 2019
Version 1.0.
8
9
Erschienen: Rockville, MD,
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services,
June 2018
Comparative effectiveness review
- number 209
von
Skelly, A.
10
- 1
- 2
- Nächster »
- [2]